QUT researchers are preparing to trial two drugs developing to treat prostate cancer as a potential treatment in fighting the worst COVID-19 symptoms.
Major symptoms, and the reason many people who have died from COVID-19 suffer acute respiratory distress syndrome which causes uncontrolled inflammation of the lungs and airways.
QUT researchers Colleen Nelson and Lisa Philp said they realised the two drugs that would reduce the size of prostate cancer tumours could prevent inflammation seen in many fatal COVID-19 cases.